Updating results…
What is Talampanel?
A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Reported Purpose & Perceived Effectiveness
| Perceived Effectiveness | |||||||
|---|---|---|---|---|---|---|---|
| Purpose | # of patients | # of patients with evaluations | Major | Moderate | Slight | None | Can’t tell |
| ALS (Amyotrophic Lateral Sclerosis) | 16 | 10 |
|
|
|
||
| Participate in clinical trial | 2 | 2 |
|
||||
See all 8 patients currently taking Talampanel
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with Talampanel
| Dizziness | 3 | |
|---|---|---|
| Excessive daytime sleepiness (somnolence) | 2 | |
| Raspy voice | 1 | |
| Depression with increased dosage | 1 | |
| disequalibrium | 1 | |
| Lethargy | 1 | |
| See all 7 reported side effects ▼ | ||
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 7 |  |
|
| Course of treatment ended | 5 | |
|
| Doctor's advice | 2 | |
|
| Side effects too severe | 2 | |
|
| Other | 2 | |
Reported Duration See details about how long patients take this treatment ▼
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Talampanel
Always |
9 | 75% |
|
|---|---|---|---|
Usually |
1 | 8% |
|
Sometimes |
1 | 8% |
|
Never |
1 | 8% |
|
Burden
Difficulty being on treatment
Burden of Talampanel
Very |
1 | 8% |
|
|---|---|---|---|
Somewhat |
1 | 8% |
|
A little |
3 | 25% |
|
Not at all |
7 | 58% |
|
Cost
Paid out of pocket
Cost of Talampanel
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
7 | 100% |
|
0 helpful marks
First
Prev
